← FDA DRUG APPROVALS

FDA ANDA · ANDA077149

TERCONAZOLE

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA077149
TYPE
ANDA
ORIGINAL APPROVAL
2006-03-17
LATEST ACTION
2016-02-20
ROUTE
VAGINAL
DOSAGE FORM
SUPPOSITORY
MARKETING STATUS
Prescription

Products

TERCONAZOLEPrescription
TERCONAZOLE 80MG · SUPPOSITORY · VAGINAL

Approval history

2016-02-20Labeling · Supplement 4 · standardAP
2006-03-17OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →